Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Seiler

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Drug Targets|October 11, 2003
Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivativesNikolaus Seiler
Current Drug Targets|October 11, 2003
Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitorsNikolaus Seiler
Neurochemistry International|May 22, 2002
Ammonia and Alzheimer's diseaseNikolaus Seiler
Pharmacology & Therapeutics|June 21, 2005
Pharmacological aspects of cytotoxic polyamine analogs and derivatives for cancer therapyNikolaus Seiler
Journal of Cellular and Molecular Medicine|October 6, 2005
Polyamines and apoptosisNikolaus Seiler, Francis Raul
International Journal of Oncology|August 3, 2007
Lysosomotropic compounds and spermine enzymatic oxidation products in cancer therapy (review)Enzo Agostinelli, Nikolaus Seiler
Critical Reviews in Clinical Laboratory Sciences|June 15, 2007
Polyamines and the intestinal tractNikolaus Seiler, Francis Raul
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|December 3, 2002
The polyamine oxidase inactivator MDL 72527Nikolaus Seiler, Benoit Duranton, Francis Raul
International Journal of Oncology|September 18, 2004
Polyploidisation of metastatic colon carcinoma cells by microtubule and tubulin interacting drugs: effect on proteolytic activity and invasivenessNikolaus Seiler, Yann Schneider, Francine Gossé, et al.
International Journal of Oncology|November 8, 2005
Cytotoxicity of the polyamine oxidase inactivator MDL 72527 to cancer cells: comparison with a saturated structural analogueNikolaus Seiler, Jacques Renault, Francine Gossé, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Drug Targets|October 11, 2003
Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivativesNikolaus Seiler
Current Drug Targets|October 11, 2003
Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitorsNikolaus Seiler
Neurochemistry International|May 22, 2002
Ammonia and Alzheimer's diseaseNikolaus Seiler
Pharmacology & Therapeutics|June 21, 2005
Pharmacological aspects of cytotoxic polyamine analogs and derivatives for cancer therapyNikolaus Seiler
Journal of Cellular and Molecular Medicine|October 6, 2005
Polyamines and apoptosisNikolaus Seiler, Francis Raul
International Journal of Oncology|August 3, 2007
Lysosomotropic compounds and spermine enzymatic oxidation products in cancer therapy (review)Enzo Agostinelli, Nikolaus Seiler
Critical Reviews in Clinical Laboratory Sciences|June 15, 2007
Polyamines and the intestinal tractNikolaus Seiler, Francis Raul
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|December 3, 2002
The polyamine oxidase inactivator MDL 72527Nikolaus Seiler, Benoit Duranton, Francis Raul
International Journal of Oncology|September 18, 2004
Polyploidisation of metastatic colon carcinoma cells by microtubule and tubulin interacting drugs: effect on proteolytic activity and invasivenessNikolaus Seiler, Yann Schneider, Francine Gossé, et al.
International Journal of Oncology|November 8, 2005
Cytotoxicity of the polyamine oxidase inactivator MDL 72527 to cancer cells: comparison with a saturated structural analogueNikolaus Seiler, Jacques Renault, Francine Gossé, et al.
Pageof 2